Philippines Orders 16 Drug Prices Halved By Mid-August
This article was originally published in PharmAsia News
Executive SummaryThe Philippines government ordered drug makers to halve the prices they charge for 16 pharmaceuticals deemed "essential," beginning Aug. 15. The government order covers only the price cuts the pharmas volunteered and it is to decide in the next few weeks on the five drugs on its list of 21 the drug makers did not volunteer. Also yet to be decided are the levels of sanctions to be imposed for violations of the new price caps. The companies offered to reduce the prices of 22 other drugs not on the government's list of 21 essential medicines. (Click here for more)
You may also be interested in...
HBW Executive Decisions: HELP Endorses Hahn, Industry Award For AHPA's McGuffin, CHPA, Herbalife Hires
CHPA adds Allgaier to head development, relations; Vetere joins Herbalife as VP, CIO; Hahn's FDA commissioner nomination clears HELP committee; and AHPA's McGuffin recognized as 2019 Industry Leader.
Almost a year after acquiring Loxo Oncology, Lilly is combining its Lilly Research Laboratories staff with a group headed by three top Loxo execs to lead cancer R&D and business development.
Tech Companies Grappling With A Brave New World Of Regulations While Developing Digital-Health Products
Software firms interested in the digital-health arena are engaging US FDA more and bolstering their regulatory credentials to navigate an unfamiliar regulatory landscape, industry experts tell Medtech Insight.